--Must See--
Groundbreaking CRISPR Therapy Set to Revolutionize Healthcare: FDA Nears Approval Decision
The field of gene editing has witnessed remarkable advancements over the past decade,...
Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician, a survey by Swiss-based pharmaceutical Novartis has...
Quality control, alignment and SNP callingThe ddRAD sequencing based genotyping of 58 individuals belonging to six native cattle breeds; Gir, Sahiwal, Tharparkar, Rathi, Red...
The past decade has seen a proliferation in the number of investigational therapies and the number of companies sponsoring active clinical trials. At the...
Pharmaceutical and biotech companies are increasingly using artificial intelligence to discover and make drugs and therapeutics. Congress on Wednesday asked the question: Does that...
Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its antibody-cell conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address...
ARTICLE | RegulationThree reasons why FDA’s meeting to discuss lecanemab will be less contentious than its aducanumab meeting By Selina Koch, Executive Editor
June 8,...
